Final report of phase II study of sorafenib, cytarabine and idarubicin for initial therapy in younger patients with acute myeloid leukemia

F. Ravandi, C. Arana Yi, J. E. Cortes, M. Levis, S. Faderl, G. Garcia-Manero, E. Jabbour, M. Konopleva, S. O'Brien, Z. Estrov, G. Borthakur, D. Thomas, S. Pierce, M. Brandt, K. Pratz, R. Luthra, M. Andreeff, H. Kantarjian

Research output: Contribution to journal › Letter › peer-review

51 Scopus citations

Fingerprint

Dive into the research topics of 'Final report of phase II study of sorafenib, cytarabine and idarubicin for initial therapy in younger patients with acute myeloid leukemia'. Together they form a unique fingerprint.